SheMed Limited

Based in the UK, SheMed Limited specializes in a weight loss program focused exclusively on women, offering personalized strategies to support health improvement and weight management. SheMed Limited is a company dedicated to women's health, particularly in weight loss management. Founded in 2024 in London, UK, the company focuses on providing tailored weight loss solutions. In October 2025, SheMed Limited raised USD 50 mn in venture funding to support its initiatives.

The founder's background details are currently not available. The company operates independently without subsidiaries or parent affiliations. SheMed specializes in a female-focused weight loss program designed to provide tailored plans for women seeking to improve their health and achieve significant weight loss. The core offering includes an initial blood screening to ensure safe and effective weight loss management, unlimited one-on-one access to clinicians, and a complimentary side effect pack that includes over-the-counter medications for common side effects associated with weight loss.

The program aims to help users lose up to 22. 5% of their body weight, while also emphasizing the importance of ongoing clinical oversight, monthly reviews, and personalized symptom management. The target clientele consists primarily of women looking for a structured approach to weight loss, and the service has been utilized by over 45,000 women. The SheMed Weight Loss Programme is marketed in the UK, with a focus on providing support and resources directly to end users through a subscription model.

SheMed generates revenue primarily through a subscription-based model for its weight loss program, with pricing set at GBP 79 for the first month and subsequent months priced from GBP 139. This structure encourages long-term engagement, allowing clients to access continuous clinical support and additional resources throughout their weight loss journey. Clients receive a comprehensive starter pack upon enrolling, which includes necessary materials such as a sharps bin and needles, and they benefit from ongoing progress tracking and weekly check-ins facilitated through an all-in-one app. The revenue stream is bolstered by the structured nature of the program; clients are likely to renew their subscriptions to maintain access to the services and support that drive their weight loss success.

In October 2025, SheMed Limited raised USD 50 mn in Series A funding to expand its operations in the UK. The company plans to scale its medical and technology teams, strengthen its clinical infrastructure, enhance data-driven capabilities, and support research and patient-experience initiatives. Specific details regarding upcoming new products are not currently available, but the funding is expected to bolster these efforts and facilitate growth.